About BIOGENES TECHNOLOGIES
BIOGENES TECHNOLOGIES is a company based in Kajang (Malaysia) founded in 2015 by Adrian Joseph. BIOGENES TECHNOLOGIES has raised $5.7 million across 2 funding rounds from investors including Cradle, Pembangunan Ekuiti and PlaTCOM Ventures. BIOGENES TECHNOLOGIES offers products and services including Animal-Free Aptamers. BIOGENES TECHNOLOGIES operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Kajang, Malaysia
- Founders Adrian Joseph
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biogenes Technologies Sdn. Bhd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.7 M (USD)
in 2 rounds
-
Latest Funding Round
$5.7 M (USD), Series A
Jan 18, 2023
-
Investors
Cradle
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BIOGENES TECHNOLOGIES
BIOGENES TECHNOLOGIES offers a comprehensive portfolio of products and services, including Animal-Free Aptamers.
Synthetic molecules for life science applications without animal components.
People of BIOGENES TECHNOLOGIES
Unlock access to complete
Unlock access to complete
Funding Insights of BIOGENES TECHNOLOGIES
BIOGENES TECHNOLOGIES has successfully raised a total of $5.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.7 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BIOGENES TECHNOLOGIES
BIOGENES TECHNOLOGIES has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Cradle, Pembangunan Ekuiti and PlaTCOM Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
MTDC is engaged in technology investment for Malaysian SMEs.
|
Locked | Locked | Locked | |
|
Early-stage investing and founder support services are offered globally by Antler.
|
Locked | Locked | Locked | |
|
Multi-asset management firm providing investments and advisory in emerging markets.
|
Locked | Locked | Locked |
Investor details for BIOGENES TECHNOLOGIES
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BIOGENES TECHNOLOGIES
Investment portfolio details for BIOGENES TECHNOLOGIES
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BIOGENES TECHNOLOGIES
Detailed financials for BIOGENES TECHNOLOGIES
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biogenes Technologies Comparisons
Peer comparison for BIOGENES TECHNOLOGIES
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BIOGENES TECHNOLOGIES
BIOGENES TECHNOLOGIES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of BIOGENES TECHNOLOGIES
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biogenes Technologies
Complete news archive for BIOGENES TECHNOLOGIES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BIOGENES TECHNOLOGIES
BIOGENES TECHNOLOGIES was founded in 2015 and raised its 1st funding round 5 years after it was founded.
BIOGENES TECHNOLOGIES is headquartered in Kajang, Malaysia. It is registered at Kajang, Selangor, Malaysia.
BIOGENES TECHNOLOGIES is a funded company, having raised a total of $5.7M across 2 funding rounds to date.
Biogenes Technologies was founded in 2015 in Kajang, Malaysia, focusing on the biotechnology sector. Molecular diagnostics and genomics technologies are developed through bio-computational methods that optimize aptamer-target binding in virtual 3D environments. Operations include in-silico design and validation of aptamers, production of DNA kits, buffers, diagnostic kits, and nano-coated sensor strips. Printed sensors with immobilized DNA probes and aptamers are also created, alongside electronic portable readers as key products.
BIOGENES TECHNOLOGIES's top competitors include Abcam, Sino Biological and DermaSensor.
BIOGENES TECHNOLOGIES offers Animal-Free Aptamers.
BIOGENES TECHNOLOGIES has 7 investors. Key investors include Cradle, Pembangunan Ekuiti, PlaTCOM Ventures, MTDC, and Ministry of Science, Technology and Innovation.